(706) An Ad Hoc Subgroup Analysis of a Phase 3, Open-Label Study Indicates Efficacy and Safety of Fecal Microbiota, Live-jslm in Participants With Recurrent Clostridioides difficile Infection and Renal Impairment

Indiana University
Indianapolis, Indiana, United States

Ferring Pharmaceuticals, Inc.
Parsippany, New Jersey, United States

Rebiotix Inc., a Ferring Company
Roseville, Minnesota, United States

Professor of Medicine
UC Davis School of Medicine
Sacramento, CA, United States

Metro Infectious Disease Consultants
Burr Ridge, Illinois, United States

CONSULTANT MICROBIOLOGIST
GST Micro LLC
NORTH, Virginia, United States